Alexander N. Parkhomenko
Narodnoho Opolchennya St, 5
Kyiv, 03680, Ukraine
Kyiv, 03680, Ukraine
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
Evolocumab in Patients without a Previous Myocardial Infarction or Stroke.
Journal: The New England journal of medicine
Published: November 10, 2025
The European BestAgeing Study on microRNA candidates reveals distinct signatures with diagnostic and prognostic potential in cardiovascular disease.
Journal: BMC medicine
Published: May 06, 2025
The Polypill (Acetyl Salicylic Acid, Atorvastatin, and Ramipril) Paradigm Shift in Secondary Prevention: Global Expert Delphi Consensus.
Journal: Global heart
Published: April 25, 2025
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.
Journal: The New England journal of medicine
Published: April 08, 2024
Empagliflozin after Acute Myocardial Infarction.
Journal: The New England journal of medicine
Published: April 08, 2024
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial.
Journal: Nature medicine
Published: March 25, 2024
Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI.
Journal: Journal of the American College of Cardiology
Published: March 12, 2024
Left Ventricular Function, Congestion, and Effect of Empagliflozin on Heart Failure Risk After Myocardial Infarction.
Journal: Journal of the American College of Cardiology
Published: February 22, 2024
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry.
Journal: The American journal of medicine
Published: July 31, 2023
Impact of quercetin in patients with myocardial infarction. A multicenter, randomized, and open-label pilot study.
Journal: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese
Published: May 29, 2023
Last Updated: 09/26/2026